Heineken announces three new projects focused on prevention and treatment of HIV/AIDS in Africa
(Thomson Reuters ONE) -
Amsterdam, 31 March 2011 - At the Heineken HIV/AIDS symposium held in Amsterdam
today, Jean-François van Boxmeer, Chairman of the Executive Board/CEO Heineken
N.V., announced that the Heineken Africa Foundation (HAF) has initiated three
new projects focused on HIV/AIDS in communities where the company operates.
* PharmAccess African Studies to Evaluate Resistance (PASER), Nigeria - PASER
is managed by the PharmAccess Foundation and is the largest coordinated
effort in sub-Saharan Africa to monitor HIV drug resistance. Six African
countries hosting 15 clinics, laboratories and research institutions are
joined in a unique collaborative network to collect data on (emerging) HIV
drug resistance. Currently, over 3,000 adults who receive antiretroviral
treatment are being monitored. With Heineken's funding Nigeria will now be
added to this study, supporting the implementation of a monitoring program
to assess the emergence of HIV drug resistance in both Nigerian adults and
children who are receiving Highly Active Antiretroviral Therapy.
* Bonnes Routes!, Democratic Republic of Congo - This programme will support
two existing road wellness clinics in Lukala and Bukavu in Northern DRC. The
clinics will provide curative and preventative health services to more than
25,000 employees of transportation companies and other community members
each year. They will provide HIV prevention guidance and ultimately HIV
treatment, as well as basic health care services. If successful, an
expansion of the programme's scope will be considered.
* Project King's Hope, South Africa - This is an ongoing project run by the
King's Hope Development Foundation. With the HAF funding, the foundation
will be able to improve the accessibility of healthcare to HIV patients in
the area of Olievenhoutbosch in the Gauteng Province, specifically
palliative care.
Jean-François van Boxmeer commented: "These three new HIV/AIDS projects
supported by the Heineken Africa Foundation will play a small but meaningful
role in helping to continue the fight against the disease in Sub-Saharan Africa.
They will help address the ongoing challenge of HIV/AIDS by increasing
knowledge, extending preventive support and providing treatment to those who are
suffering."
Under the theme "Sharing Responsibilities in the 'World of Work' in Africa," the
Heineken HIV/AIDS symposium brought together leading figures from national
government, NGOs, the public health community and industry to take stock,
challenge conventional thinking and stimulate new ideas. The symposium reflected
on three key issues: access to medication, resistance to treatment and the gap
in funding.
Heineken was particularly honored by the participation in the symposium of Mr.
Ben Knapen, the Netherlands Minister for European Affairs and International Co-
operation. In his keynote speech "A Government Perspective," Mr. Knapen stressed
the importance of initiatives such as the Heineken Africa Foundation:
"My government believes that public-private partnerships are an important tool
in the fight against HIV/AIDS. Bringing together partners from both the public
and private sectors creates the synergy and leverage we need in order to step up
our efforts."
Other expert speakers participating in the symposium were:
* Dr. Hedia Belhadj, Director, Partnerships Department, UNAIDS
* Prof. Dr. Joep M.A. Lange, Department of Global Health, Academic Medical
Centre, University of Amsterdam, Amsterdam Institute for Global Health and
Development
* Ms. Morolake Odetoyinbo, Board Member, The Global Fund; CEO, Positive Action
for Treatment Access
* Mr. Hugo Tempelman MD, MA, CEO Ndlovu Care Group, South Africa; visiting
professor Utrecht University
* Dr. Marijke Wijnroks, AIDS Ambassador, The Dutch Government
In addition to Chairman/CEO Jean-François van Boxmeer, other Heineken employees
presenting at the symposium were Tom de Man, Regional President Africa & Middle
East, Hans van Mameren, General Manager Bralima, Democratic Republic of Congo,
and Dr. Stefaan Van der Borght, Director Global Health Affairs.
On March 30, Dr. Van der Borght successfully defended his doctoral thesis
"Making HIV programmes work. The Heineken workplace programme to prevent and
treat HIV infection 2001 - 2010" at the University of Amsterdam.
A replay of the HIV/AIDS symposium's webcast, as well as additional information
on the Heineken Africa Foundation is available on the Heineken International
website:
http://www.heinekeninternational.com/web+casts+press.aspx
The HIV/AIDS symposium is part of the "Heineken Cares" initiative, under the
umbrella of the company's long-term sustainability approach "Brewing a Better
Future".
Press enquiries:
Hester Swart
Tel: +31 20 5239 355
Email:hester.swart(at)heineken.com
John-Paul Schuirink
Tel: +31 20 5239 355
Email:john-paul.schuirink(at)heineken.com
About Brewing a Better Future
'Brewing a Better Future' is Heineken's long-term sustainability initiative. The
23 integrated programmes that make up the initiative focus on improving the
environmental impact of Heineken's brands and business, empowering people and
the communities in which Heineken operates and positively impacting the role of
beer in society. Amongst the commitments Heineken has made as part of its
approach to sustainability are:
* By 2020 a reduction of specific direct and indirect CO(2) emissions in
breweries by at least 40% and a reduction in specific water consumption by
at least 25%.
* To expand to ?20 million the funding for the Heineken Africa Foundation.
* To expand the local sourcing of raw materials in Africa to 60% by 2020.
* The continuous reduction of the CO(2) footprint of our brands throughout the
value chain.
* By 2015 ensuring that all markets have a partnership that help the company
play its part in reducing alcohol abuse.
* By 2015 for every majority-owned business to have a sustainability plan and
to report publicly on its progress and commitment.
For more information on 'Brewing a Better Future', visit
www.heinekeninternational.com/sustainability
About Heineken:
Heineken is one of the world's great brewers and is committed to growth and
remaining independent. The brand that bears the founder's family name - Heineken
- is available in almost every country on the globe and is the world's most
valuable international premium beer brand. The Company's aim is to be a leading
brewer in each of the markets in which it operates and to have the world's most
valuable brand portfolio. The Company operates 140 breweries in more than 70
countries and sold 205 million hectolitres of beer on a 2010 pro-forma basis.
Heineken is Europe's largest brewer and the world's third largest by volume.
Heineken is committed to the responsible marketing and consumption of its more
than 200 international premium, regional, local and specialty beers and ciders.
These include Amstel, Birra Moretti, Cruzcampo, Dos Equis, Foster's, Kingfisher,
Newcastle Brown Ale, Ochota, Primus, Sagres, Sol, Star, Strongbow, Tecate, Tiger
and Zywiec. On a 2010 pro-forma basis, including FEMSA Cerveza, revenue totalled
?17 billion and EBIT (beia) was ?2.7 billion. The average number of people
employed is more than 70,000. Heineken N.V. and Heineken Holding N.V. shares are
listed on the Amsterdam stock exchange. Prices for the ordinary shares may be
accessed on Bloomberg under the symbols HEIA NA and HEIO NA and on the Reuter
Equities 2000 Service under HEIN.AS and HEIO.AS. Most recent information is
available on Heineken's website: www.heinekeninternational.com.
Download Heineken International press release.pdf:
http://hugin.info/136188/R/1501990/437398.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Heineken International via Thomson Reuters ONE
[HUG#1501990]
Unternehmensinformation / Kurzprofil:
Datum: 31.03.2011 - 16:00 Uhr
Sprache: Deutsch
News-ID 53031
Anzahl Zeichen: 9300
contact information:
Town:
Amsterdam
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Heineken announces three new projects focused on prevention and treatment of HIV/AIDS in Africa"
steht unter der journalistisch-redaktionellen Verantwortung von
Heineken International (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
